MiMedx Group Inc. (MDXG)

NASDAQ: MDXG · Real-Time Price · USD

6.34

-0.54 (-7.85%)

At close: May 01, 2025, 3:56 PM

6.32

-0.39%

After-hours: May 01, 2025, 04:00 PM EDT

-7.85% (1D)

Bid	6.24
Market Cap	935.04M
Revenue (ttm)	348.88M
Net Income (ttm)	42.42M
EPS (ttm)	0.28
PE Ratio (ttm)	22.66
Forward PE	19.18
Analyst	Buy

Ask	6.45
Volume	1,382,438
Avg. Volume (20D)	552,745
Open	6.60
Previous Close	6.88
Day's Range	6.17 - 6.63
52-Week Range	5.47 - 10.14
Beta	1.75

About MDXG

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its produc...

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Feb 12, 2008

Employees 837

Stock Exchange NASDAQ

Ticker Symbol MDXG

Website https://www.mimedx.com

Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for MDXG stock is "Buy." The 12-month stock price forecast is $12, which is an increase of 89.13% from the latest price.

Stock Forecasts

Earnings Surprise

New

MiMedx has released their quartely earnings on Apr 30, 2025:

Revenue of $88.2M exceeds estimates by $1.89M, with 4.13% YoY growth.

EPS of 0.06 exceeds estimates by 0.01, with -14.29% YoY decline.

Why Price Moved

5 months ago

+23.56%

MiMedx Group shares are trading higher after the c... Unlock content with Pro Subscription

6 months ago

+20.39%

MiMedx Group shares are trading higher after the company reported better-than-expected Q3 financial results.

News

22 hours ago · seekingalpha.com

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

MiMedx Group, Inc. (NASDAQ:MDXG ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Matthew Notarianni - Head, IR Joseph Capper - CEO & Director Doug Rice - CFO Conferenc...

1 day ago · zacks.com

MiMedx (MDXG) Q1 Earnings Match Estimates

MiMedx (MDXG) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.07 per share a year ago.

2 months ago · seekingalpha.com

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

MiMedx Group, Inc. (NASDAQ:MDXG ) Q4 2024 Earnings Conference Call February 26, 2024 4:30 AM ET Company Participants Matt Notarianni - Head, Investor Relations Joseph Capper - Chief Executive Officer ...

2 months ago · zacks.com

MiMedx (MDXG) Q4 Earnings Meet Estimates

MiMedx (MDXG) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago.